Latest CRISPR patent pool stops short at research applications

The announcement that the Broad Institute and MilliporeSigma will offer combined licenses to CRISPR IP is the latest step toward simplifying the CRISPR IP landscape, but the licenses will be limited to research applications.

Given the controversy

Read the full 367 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE